Thank you for your recent subscription to FDA’s Generic Drugs Updates

If your email program has trouble displaying this email, view as a webpage.

Thank you for your recent subscription to FDA’s Generic Drugs Updates!

We are writing to let you know you can tailor the emails you receive to reflect your specific areas of interest within the Generic Drugs Program. Sharing your topic preferences will help us send you customized information based on your unique interests.

FDA’s generic drugs updates span a variety of topics, including:

• Policy updates (new guidances, MAPPs, etc.)
• Event updates (webinars, conferences, etc.)
• GDUFA updates (reauthorization, accomplishments, etc.)
• Drug Competition Action Plan updates (drug pricing, accomplishments, etc.)
• Science & research updates (priorities, reports, etc.)
• Pharmaceutical quality updates (guidances, reports, etc.)
• Noteworthy generic drug approvals
• Generic drug safety updates
• Global generic drug program updates